Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and laboratory space will

With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the

Using a special gas treatment, the Fribourg-based company Medistri suppresses all germs contained in the vials destined to receive the Covid-19 vaccine. The company expects

With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and

With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the

Researchers from EPFL have invented a technique to navigate electronic devices that are smaller than human hair inside blood vessels and reach arterioles. The next

With the launch of its CE-Mark certified device cSOFA, which assesses the severity of Covid-19 among patients within only five minutes of analyzing a blood

With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and

Valued at CHF 86 million and scheduled to be operational in 2024, the Pôle Santé campus aims to be a platform for the exchange of

The Swiss Integrative Center for Human Health (SICHH) and EIKON, Fribourg’s Vocational School of Applied Arts, have launched a new scientific communication platform called “Connect

Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The new YpsoMate Zero uses alternative biopolymers and a novel packaging design that follows

Lonza’s new building dedicated to the manufacturing of Moderna’s Covid-19 vaccine will be operational starting December 2020. 300 million doses will be produced annually at

Global leader in data-driven medicine SOPHiA GENETICS has closed a $110 million financing round to enter the next stage of its expansion, with a focus

Rheon Medical is revolutionizing glaucoma treatment with its eyeWatch system, in which Coat-X’s coating technology plays a central role. Both start-ups were awarded prizes at

CERN and Lausanne University Hospital (CHUV) are collaborating to develop the conceptual design of an innovative radiotherapy facility used for cancer treatment. CERN, in the

The Immunology and Allergy Department of Lausanne University Hospital has received European funding of nearly CHF 5 million for its research aimed at identifying antibodies

The glass slides used to prepare samples for looking at under a microscope have hardly changed in the nearly 200 years since their invention. Breaking

Open to both research and industry, the new BSL-3 biosafety laboratory at the University of Bern Institute of Infectious Diseases can be used by external

A recent innovation from the EPFL Laboratory of Stem Cell Bioengineering will enable the mass production of standardized organoids for the first time. This scalable

Swiss start-up Adamant Innotech and CSEM are developing a rapid serological test to determine if a person has been previously infected with the SARS‐CoV‐2 virus

EPFL students have teamed up with start-up IcosaMed to develop the SmartBra, the first piece of smart clothing that can be used for cancer prevention.

The most sought after product in the midst of the COVID-19 pandemic is a Swiss invention. The hydro-alcoholic gel was formulated in the 1970s by

A team of researchers from the University of Fribourg has shown that the analysis of the microbial flora present in the saliva enables the early

The Idiap research institute now hosts a bioinformatics research group focusing on amyotrophic lateral sclerosis.   Known above all for its advances in the fields